Article
Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.
Metabolic brain disease - 1 Feb 2016
Lückhoff H K, Kidd M, van Rensburg S J, van Velden D P, Kotze M J
Abstract excerpt
The cholesterol-raising properties of the apolipoprotein E (APOE) epsilon-4 (ε-4) allele has been validated in the South African population. Mounting evidence supports the added value of APOE genotyping for the evaluation of cardiovascular risk in dyslipidemic patients beyond its established role in the diagnosis of late-onset Alzheimer's disease (AD). The aim of this study was to determine the potential benefits...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.